← Back to Clinical Trials
Recruiting NCT05397717

Prospective Study on Clinical Outcomes of Spontaneous Pneumothorax

Trial Parameters

Condition Pneumothorax, Spontaneous
Sponsor Chinese University of Hong Kong
Study Type OBSERVATIONAL
Phase N/A
Enrollment 349
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-10-01
Completion 2025-09-30
Interventions
observational

Brief Summary

Pneumothorax can be fatal if treatment is delayed or the pneumothorax is refractory. However, the mortality rates and their risk factors were mainly reported from retrospective studies, and local data regarding the mortality of spontaneous pneumothorax is scarce. This study aims at evaluating the in-hospital mortality and relevant clinical outcomes of spontaneous pneumothorax and identifying their predictive factors. The data collected from this study will also guide the planning of subsequent research to overcome the knowledge and service gap in managing spontaneous pneumothorax.

Eligibility Criteria

Inclusion criteria * All patients with a confirmed diagnosis of spontaneous pneumothorax on admission or during the hospital stay * Age greater than 18 years old * Chinese ethnicity * Able to sign written informed consent to participate in the study Exclusion criteria * Pneumothorax was not found by thoracic imaging * Traumatic pneumothorax (including iatrogenic pneumothorax) * Pneumothorax with recent (within one month) lung resection surgery, that may be due to staple line issues * Trapped lung or non-expandable lungs, without evidence of air leakage * Patients with psychiatric disease or cognitive impairment that may limit their ability of understanding or giving consent to the study

Related Trials